Case Reports
doi: 10.3748/wjg.v12.i12.1978.
Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkn's lymphoma patient
- PMID: 16610013
- PMCID: PMC4087532
- DOI: 10.3748/wjg.v12.i12.1978
Item in Clipboard
Case Reports
Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkn's lymphoma patient
World J Gastroenterol.
.
No abstract available
Comment in
-
Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximab.World J Gastroenterol. 2006 Dec 7;12(45):7391. doi: 10.3748/wjg.v12.i45.7391. World J Gastroenterol. 2006. PMID: 17143963 Free PMC article.
Similar articles
-
Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximab.World J Gastroenterol. 2006 Dec 7;12(45):7391. doi: 10.3748/wjg.v12.i45.7391. World J Gastroenterol. 2006. PMID: 17143963 Free PMC article.
-
Cytomegalovirus gastritis after treatment with rituximab.Endoscopy. 2009;41 Suppl 2:E199. doi: 10.1055/s-0029-1214855. Epub 2009 Jul 27. Endoscopy. 2009. PMID: 19637127 No abstract available.
-
Changes in hepatitis C virus antibody titer and viral RNA load in non-Hodgkin's lymphoma patients after rituximab chemotherapy.Int J Lab Hematol. 2009 Aug;31(4):468-70. doi: 10.1111/j.1751-553X.2008.01034.x. Epub 2008 Feb 14. Int J Lab Hematol. 2009. PMID: 18294236 Free PMC article. No abstract available.
-
Rituximab immunotherapy for non-Hodgkin's lymphoma.Cancer Biother Radiopharm. 1999 Aug;14(4):241-50. doi: 10.1089/cbr.1999.14.241. Cancer Biother Radiopharm. 1999. PMID: 10850310 Review.
-
Evolving role of rituximab in the treatment of patients with non-Hodgkin's lymphoma.Future Oncol. 2005 Jun;1(3):297-306. doi: 10.1517/14796694.1.3.297. Future Oncol. 2005. PMID: 16556002 Review.
Cited by
-
Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximab.World J Gastroenterol. 2006 Dec 7;12(45):7391. doi: 10.3748/wjg.v12.i45.7391. World J Gastroenterol. 2006. PMID: 17143963 Free PMC article.
-
Does rituximab increase the incidence of infectious complications? A narrative review.Int J Infect Dis. 2011 Jan;15(1):e2-16. doi: 10.1016/j.ijid.2010.03.025. Epub 2010 Nov 11. Int J Infect Dis. 2011. PMID: 21074471 Free PMC article. Review.
-
Gastric Outlet Obstruction due to Cytomegalovirus Infection in an Immunocompromised Patient.Case Rep Gastroenterol. 2009 Sep 12;3(3):280-285. doi: 10.1159/000228895. Case Rep Gastroenterol. 2009. PMID: 21103242 Free PMC article.
References
-
- Czuczman MS, Grillo-López AJ, White CA, Saleh M, Gordon L, LoBuglio AF, Jonas C, Klippenstein D, Dallaire B, Varns C. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol. 1999;17:268–276. - PubMed
-
- Suzan F, Ammor M, Ribrag V. Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. N Engl J Med. 2001;345:1000. - PubMed
-
- Goldberg SL, Pecora AL, Alter RS, Kroll MS, Rowley SD, Waintraub SE, Imrit K, Preti RA. Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood. 2002;99:1486–1488. - PubMed
-
- Benson AB 3rd, Ajani JA, Catalano RB, Engelking C, Kornblau SM, Martenson JA Jr, McCallum R, Mitchell EP, O'Dorisio TM, Vokes EE, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol. 2004;22:2918–2926. - PubMed
-
- Perez CA, Brady LW, eds . : Principles and Practice of Radiation Oncology. 3rd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1998.
